Intrinsic Value of S&P & Nasdaq Contact Us

Roche Holding AG RHHBY OTC

Other OTC • Healthcare • Drug Manufacturers - General • CH • USD

SharesGrow Score
68/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$48.00
-5.9%
SharesGrow 7-Criteria Score All 7 criteria scored · income-related highlighted on this page

Roche Holding AG (RHHBY) has shown moderate revenue growth over the past 3 years, expanding from $63.3B to $63.4B (average +0.1%/yr). Net income reached $12.9B, reflecting solid earnings growth at +6.7%/yr on average. The net profit margin is 20.3%, which is high. The company has maintained profitability in all 4 of the past 4 years, demonstrating a consistent earnings track record. The gross margin is 73.7% (high), with a +3.5pp trend over the period. With a $329B market cap and MOAT composite score of 94/100, the company has a strong competitive position.

Criteria proven by this page:

  • GROWTH (55/100, Partial) — growth is present but not consistently above 5% across both metrics
  • PAST (100/100, Pass) — proving consistent earnings. Looking at the full 28-year history, the company was profitable in 27 of 28 years — an excellent long-term track record
  • INCOME (85/100, Pass) — proves strong profitability and pricing power
  • MOAT (94/100, Pass) — strong gross margins and market scale prove a durable competitive advantage

Overall SharesGrow Score: 68/100 with 3/7 criteria passed.

68/100
SG Score
View full scorecard →
~
VALUE
46/100
Price-to-Earnings & upside
→ IV page
FUTURE
26/100
Analyst consensus
→ Forecast
PAST
100/100
4/4 yrs profit
EPS $1.91
Proven by this page
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
MOAT
94/100
Score: 94/100
GM 73.7% (+3.5pp)
Proven by this page
~
GROWTH
55/100
Rev +0.1%/yr
NI +6.7%/yr
Proven by this page
INCOME
85/100
Margin 20.3%
$63.4B
Proven by this page
Roche Holding AG Earnings and Revenue History
Revenue
Earnings & Profit Margin
Metric TTM FY2025 FY2024 FY2023 FY2022
Revenue $108.64B$63.36B$62.4B$60.44B$63.28B
Gross Profit $79.91B$46.71B$46.11B$44.08B$44.44B
Gross Margin 73.6%73.7%73.9%72.9%70.2%
Operating Income $27.41B$18.48B$13.42B$15.4B$18.18B
Net Income $17.41B$12.88B$8.28B$11.5B$12.42B
Net Margin 16%20.3%13.3%19%19.6%
EPS (Diluted) $2.71$1.91$1.29$1.79$1.94
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message